Oestrogen-replacement therapy.
D002273:Carcinogens; D004359:Drug Therapy, Combination; D004714:Endometrial Hyperplasia / Q000517:prevention & control; D004715:Endometriosis / Q000139:chemically induced; D045166:Estradiol Congeners / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D045167:Progesterone Congeners / Q000008:administration & dosage; D014594:Uterine Neoplasms / Q000139:chemically induced
D002273:Carcinogens; D045166:Estradiol Congeners; D045167:Progesterone Congeners